Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01321476

Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Piedmont Healthcare · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will use excess tissue from endoscopic or surgical procedures to examine the elements of plaque that are found in the carotid walls of patients who have a type of heart and blood vessel disease called atherosclerosis. Tissue will be collected from patients undergoing carotid procedures as well as patients undergoing liver and/or intestinal biopsies. This lab study will examine the different types of proteins that play a role in developing heart plaque.

Conditions

Timeline

First posted
2011-03-23
Last updated
2013-09-05

Source: ClinicalTrials.gov record NCT01321476. Inclusion in this directory is not an endorsement.

Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis (NCT01321476) · Clinical Trials Directory